fig1

Targeted therapies in cancer: where are we going?

Figure 1. Interaction between chemotherapy and anti-EGFR agents: data from preclinical studies

Cancer Drug Resistance
ISSN 2578-532X (Online)

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/